2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Trickler WJ et al. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. 2010 AAPS PharmSciTech pmid:20238190
Salentinig S et al. Self-assembled structures and pKa value of oleic acid in systems of biological relevance. 2010 Langmuir pmid:20578757
Mulet X et al. High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles. 2010 Int J Pharm pmid:20580796
Nguyen TH et al. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. 2010 J. Pharm. Pharmacol. pmid:20636872
Nguyen TH et al. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation. 2010 J. Pharm. Pharmacol. pmid:20636873
Yaghmur A et al. Effects of pressure and temperature on the self-assembled fully hydrated nanostructures of monoolein-oil systems. 2010 Langmuir pmid:19681634
Issa JP et al. Collagen fibers evaluation after rhBMP-2 insertion in critical-sized defects. 2009 Jul-Aug Micron pmid:19394235
Long JZ et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. 2009 Nat. Chem. Biol. pmid:19029917
Ericsson EM et al. Glycerol monooleate-blood interactions. 2009 Colloids Surf B Biointerfaces pmid:18996684
Biradar SV et al. Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery. 2009 Pharm Dev Technol pmid:18802845
Ahmed AR and Bodmeier R Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. 2009 Eur J Pharm Biopharm pmid:18840521
Lee KW et al. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. 2009 Int J Pharm pmid:18790030
Libster D et al. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A. 2009 Int J Pharm pmid:18977286
Pichot R et al. Mixed-emulsifier stabilised emulsions: Investigation of the effect of monoolein and hydrophilic silica particle mixtures on the stability against coalescence. 2009 J Colloid Interface Sci pmid:18977494
Uyama M et al. Useful modified cellulose polymers as new emulsifiers of cubosomes. 2009 Langmuir pmid:19296640
Fong WK et al. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. 2009 J Control Release pmid:19331865
Rizwan SB et al. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. 2009 J Pharm Sci pmid:19340889
Vandoolaeghe P et al. Neutron reflectivity studies of the interaction of cubic-phase nanoparticles with phospholipid bilayers of different coverage. 2009 Langmuir pmid:19714826
Vandoolaeghe P et al. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction. 2009 Langmuir pmid:19714888
Issa JP et al. Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles. 2009 Clin Oral Implants Res pmid:19719732